Deal type
Capital Markets & IPO
1,905 announced Capital Markets & IPO deals, most recent first, with the firms that advised on each.
Most recent
SEARCH ALL 1,905 Dentons advises Vancity on two capital markets transactions totalling CA$550 million 3 Nov 2026
Hogan Lovells Cadwalader advises DZ BANK on base prospectus for crypto securities 3 Nov 2026
Clifford Chance advises on Eurasian Development Bank’s debut Dim Sum bond 3 Nov 2026
Latham Advises on Aspen Neuroscience’s US$140.6 Million IPO 3 Nov 2026
Latham & Watkins Advises on Bambusa Therapeutics’ Upsized US$168.9 Million IPO 3 Nov 2026
Latham Advises on Essential Properties Realty Trust, Inc.’s US$450 Million Exchangeable Senior Notes Offering 29 Oct 2026
Latham Advises Jio Platforms on INR 301,876 Million (US$3.2 Billion) IPO 29 Oct 2026
Linklaters advises thyssenkrupp on the spin-off and listing of tk accelis 29 Oct 2026
DLA Piper advises underwriters in Strive’s US$630 million preferred stock initial public offering 28 Oct 2026
DLA Piper advises AI-native specialty insurance platform Ledgebrook on primary equity financing 28 Oct 2026
DLA Piper advises Retension Pharmaceuticals on initial public offering 28 Oct 2026
Linklaters advises on Runwal Enterprises Limited’s IPO in India 28 Oct 2026
Dentons advises FAB on AED 1 billion MENA-first digitally native green bond 27 Oct 2026
Clifford Chance advises the underwriters on CAF’s US$2 billion notes offering 27 Oct 2026
Clifford Chance advises on MUFG’s inaugural Australian dollar AT1 issuance 27 Oct 2026
Latham Advises on Corxel Pharmaceuticals and Amanat Acquisition Corp.’s Business Combination Agreement to Create a Publicly Listed Obesity-Focused Biopharmaceutical Company 27 Oct 2026
Latham Advises on Zetwerk’s US$529 Million IPO 27 Oct 2026
Latham & Watkins Advises Arcus Biosciences on US$250 Million Public Offering of Common Stock 27 Oct 2026
Linklaters advises BOC on two landmark offshore Renminbi notes issuances in Dubai and Europe 27 Oct 2026
Linklaters advises on Adani Group company Cemindia Projects’ US$146m qualified institutional placement of shares in India 27 Oct 2026
Linklaters advises Schneider Electric on its €6bn share capital increase 27 Oct 2026
News Clifford Chance advises on MUFG’s inaugural Australian dollar AT1 issuance 22 Oct 2026
Linklaters advises Joint Lead Managers on first benchmark DLT-native sovereign bond issuance by the Grand Duchy of Luxembourg 22 Oct 2026
Herbert Smith Freehills Kramer advises Airtel Africa plc on IPO 21 Oct 2026
Clifford Chance advises the Lao People’s Democratic Republic on US$500 million Reg S/144A bond issuance 21 Oct 2026
Latham Advises on Mynt’s ₱53 Billion IPO 21 Oct 2026
TriGemX Bio, a biotechnology company focused on developing elismetrep, a potential first-in-class treatment for migraine, and TCGX Acquisition Corp. (Nasdaq: TCGX), a special purpose acquisition company (SPAC) sponsored by TCGX, have announced the execution of a definitive business combination agreement that will result in TriGemX Bio becoming a publicly traded company. The combined company will be named TriGemX Bio, Inc. and is expected to trade on Nasdaq under the new ticker symbol TGEM. Latham & Watkins LLP represents TCGX in the transaction with a corporate team led by Houston partners Ryan Maierson and Ryan Lynch, with associates Taylor Allison, Cooper Shear, and Luisa Gomez Yokubaitis, with assistance from Zachary Mouton. Advice was also provided on tax matters by Houston partner Jared Grimley, with associates Dominick Constantino and Graham Core; on benefits matters by Los Angeles partner Michelle Carpenter, with associate Jordan Barnes; on healthcare regulatory matters by Washington, D.C. partner Nathan Beaton and counsel Nicole Liffrig Molife and Chad Jennings, with associate Margaret Rote; on funds matters by Chicago partner David Moore and New York partner Jennifer Tian;* on data cybersecurity matters by New York partner Jessica Cohen, with associates Laura Geraci and Nat Lewis; on data privacy and cybersecurity matters by Bay Area partner Heather Deixler, with associate Ryleigh Chen; on environmental matters by Los Angeles/Houston partner Joshua Marnitz, with associate Brandon Kerns; on anti-bribery and anti-money laundering matters by Washington, D.C. partner Daniel Dominguez, with associates Patricia Amselem Bensadon and Ai Ni Lim; on antitrust matters by Washington, D.C. partner Jason Cruise and Washington, D.C. counsel Ngoc Hulbig; and on economic sanctions and export controls matters by Washington, D.C. partner Eric Volkman, with associate Amulya Vadapalli. *Admitted to practice in Illinois only. 21 Oct 2026
Latham Advises Institutional Investors on Kapla Holding’s €100 Million Private Placement 21 Oct 2026
Linklaters advises Joint Bookrunners on DFMG Holding’s €1bn inaugural public bond issuance 21 Oct 2026
Sidley Represents Cipher Digital in US$850 Million Senior Notes Offering 19 Oct 2026
DLA Piper guides First Digital through De-SPAC business combination with KOYN 19 Oct 2026
Dentons advises Uzbekistans Tourism and Entertainment Group 19 Oct 2026
Hogan Lovells Cadwalader advises Banco Santander and UniCredit on the restructuring of ViViBanca’s CQS securitisation 19 Oct 2026
Clifford Chance advises GD Towers on its €1 billion debut public bond 19 Oct 2026
Clifford Chance advises on Transsion’s Hong Kong IPO and listing 19 Oct 2026
Latham & Watkins Advises Latin American Development Bank Corporación Andina de Fomento in US$2 Billion Bond Financing 19 Oct 2026
Linklaters advises on CIG Shanghai’s concurrent new H-share placing and convertible bond offering 19 Oct 2026
Mayer Brown advises The Smarter Web Company on first-of-its-kind UK preferred share offering 15 Oct 2026
Latham & Watkins Advises Bending Spoons on US$330 Million Investment From Berkshire Hathaway 15 Oct 2026
Latham Advises on Cipher Digital’s US$850 Million Convertible Senior Notes Offering and Concurrent Notes Exchange 15 Oct 2026
Linklaters advises banks on a new agented CMBS for Mileway UK 15 Oct 2026
Latham & Watkins Advises Initial Purchasers on €1 Billion High-Yield Bond Issuance by Guala Closures 14 Oct 2026
Latham & Watkins Advises on Evernorth De-SPAC Transaction 14 Oct 2026
Hogan Lovells Cadwalader advises on the €62.5 million ABB of Gens Aurea 12 Oct 2026
Clifford Chance advises on ESWIN Computing’s Hong Kong IPO and listing 12 Oct 2026
Latham & Watkins Advises Leading On-Demand Pay Unicorn DailyPay in US$200 Million Asset-Backed Securitization 12 Oct 2026
Latham Advises on TRexBio’s US$116.7 Million Initial Public Offering 12 Oct 2026
Hogan Lovells Cadwalader advises Joint Lead Managers on Spuerkeess’ inaugural covered bond issuance under new Luxembourg bond legislation 9 Oct 2026
Clifford Chance advises managers on Principality of Andorra’s €500 million sustainability bonds issuance 9 Oct 2026
Clifford Chance advises the UAE Ministry of Finance on its landmark sovereign retail treasury sukuk programme and initial issuances 8 Oct 2026
Clifford Chance advises TRATON on inaugural Green Bond 8 Oct 2026
Latham Advises on Vaxcyte’s Concurrent Public Offerings of Common Stock, Pre-Funded Warrants, and Convertible Senior Notes 8 Oct 2026
Hogan Lovells Cadwalader advises UniCredit on the authorisations for the landmark €5bn USD-denominated AT1 issuance 7 Oct 2026
Clifford Chance advises on Clifford Capital’s US$802.4 million infrastructure asset-backed securities issuance 7 Oct 2026
Linklaters advises Lenzing AG on approximately €300m rights issue 6 Oct 2026
Linklaters advises Warehouses De Pauw on its €400 million capital increase 6 Oct 2026
Hogan Lovells Cadwalader advises Credem on the renewal of its €1 billion Multi-Currency Commercial Paper Programme 3 Oct 2026
Clifford Chance advises banks on Bayer Aktiengesellschaft’s €2 billion Dual-Tranche Hybrid Bond Issuance 3 Oct 2026
Latham Advises on Corteva and Vylor’s US$1.4 Billion Exchange Offers and Consent Solicitations 3 Oct 2026
Linklaters advises on IRB InvIT Fund’s INR 20bn qualified institutional placement of units 3 Oct 2026